News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CombiMatrix Corporation (CBMX) Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement



12/20/2012 9:23:06 AM

IRVINE, Calif., Dec. 20, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for prenatal, pediatric and oncology, today announced that it has received a letter from the NASDAQ Stock Market notifying the Company that it has regained full compliance with NASDAQ's minimum bid continued listing requirement.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES